Literature DB >> 16251534

Effect of screening and adjuvant therapy on mortality from breast cancer.

Donald A Berry1, Kathleen A Cronin, Sylvia K Plevritis, Dennis G Fryback, Lauren Clarke, Marvin Zelen, Jeanne S Mandelblatt, Andrei Y Yakovlev, J Dik F Habbema, Eric J Feuer.   

Abstract

BACKGROUND: We used modeling techniques to assess the relative and absolute contributions of screening mammography and adjuvant treatment to the reduction in breast-cancer mortality in the United States from 1975 to 2000.
METHODS: A consortium of investigators developed seven independent statistical models of breast-cancer incidence and mortality. All seven groups used the same sources to obtain data on the use of screening mammography, adjuvant treatment, and benefits of treatment with respect to the rate of death from breast cancer.
RESULTS: The proportion of the total reduction in the rate of death from breast cancer attributed to screening varied in the seven models from 28 to 65 percent (median, 46 percent), with adjuvant treatment contributing the rest. The variability across models in the absolute contribution of screening was larger than it was for treatment, reflecting the greater uncertainty associated with estimating the benefit of screening.
CONCLUSIONS: Seven statistical models showed that both screening mammography and treatment have helped reduce the rate of death from breast cancer in the United States. Copyright 2005 Massachusetts Medical Society.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16251534     DOI: 10.1056/NEJMoa050518

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  743 in total

1.  Breast cancer survivors' perceptions of survivorship care options.

Authors:  Erica L Mayer; Adrienne B Gropper; Bridget A Neville; Ann H Partridge; Danielle B Cameron; Eric P Winer; Craig C Earle
Journal:  J Clin Oncol       Date:  2011-12-12       Impact factor: 44.544

2.  High resolution dual detector volume-of-interest cone beam breast CT--Demonstration with a bench top system.

Authors:  Youtao Shen; Ying Yi; Yuncheng Zhong; Chao-Jen Lai; Xinming Liu; Zhicheng You; Shuaiping Ge; Tianpeng Wang; Chris C Shaw
Journal:  Med Phys       Date:  2011-12       Impact factor: 4.071

3.  Longitudinal patterns in survival, comorbidity, healthcare utilization and quality of care among older women following breast cancer diagnosis.

Authors:  Amresh D Hanchate; Kerri M Clough-Gorr; Arlene S Ash; Soe Soe Thwin; Rebecca A Silliman
Journal:  J Gen Intern Med       Date:  2010-06-08       Impact factor: 5.128

4.  The impact of obesity on the rise in esophageal adenocarcinoma incidence: estimates from a disease simulation model.

Authors:  Chung Yin Kong; Kevin J Nattinger; Tristan J Hayeck; Zehra B Omer; Y Claire Wang; Stuart J Spechler; Pamela M McMahon; G Scott Gazelle; Chin Hur
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-09-19       Impact factor: 4.254

5.  It's not an easy fix: Adherence to adjuvant endocrine therapy after breast cancer.

Authors:  Leah K Lambert; Lynda G Balneaves; A Fuchsia Howard
Journal:  Can Oncol Nurs J       Date:  2021-05-01

6.  Long-term follow-up for cardiovascular disease after chemotherapy and/or radiotherapy for breast cancer in an unselected population.

Authors:  L M Boerman; A J Berendsen; P van der Meer; J H Maduro; M Y Berger; G H de Bock
Journal:  Support Care Cancer       Date:  2014-03-02       Impact factor: 3.603

7.  Can magnetic resonance imaging obviate the need for biopsy for microcalcifications?

Authors:  Shinya Yamamoto; Takashi Chishima
Journal:  Gland Surg       Date:  2017-08

8.  Calponin-h2: a potential serum marker for the early detection of human breast cancer?

Authors:  Manuel Debald; Jian-Ping Jin; Andrea Linke; Klaus-Jürgen Walgenbach; Peter Rauch; Angela Zellmer; Rolf Fimmers; Walther Kuhn; Gunther Hartmann; Gisela Walgenbach-Brünagel
Journal:  Tumour Biol       Date:  2014-08-07

Review 9.  Anthracycline Use for Early Stage Breast Cancer in the Modern Era: a Review.

Authors:  Sakshi Jasra; Jesus Anampa
Journal:  Curr Treat Options Oncol       Date:  2018-05-11

10.  Impact of high-deductible insurance on adjuvant hormonal therapy use in breast cancer.

Authors:  Christine Y Lu; Fang Zhang; Anita K Wagner; Larissa Nekhlyudov; Craig C Earle; Matthew Callahan; Robert LeCates; Xin Xu; Dennis Ross-Degnan; J Frank Wharam
Journal:  Breast Cancer Res Treat       Date:  2018-05-12       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.